BioScience Valuation (BSV) is a consulting company working at the intersection of life sciences and finance. BSV is a trusted partner for Pharma and Biotech companies and their investors, with a 500+ mandates track record of private and public clients in Europe, the US, and worldwide.

Since 2000, the company has been at the forefront of translating scientific innovation into financial value. Our services cover the entire spectrum of commercial, R&D and financial analyses and deliver unparalleled evidence-based assessments. Based on our profound subject expertise and comprehensive database coverage, our appraisals demonstrate the route to value creation from seed stage to IPO and beyond. Our strategic alliances enable us to reach out into the US and other markets and to communicate client equity stories within the international investor community.

Contact

Joachim M. Greuel PhD., MBH, Managing Director, Co-Founder j.m.greuel@bioscience-valuation.com	Kerstin M. Bode-Greuel MD, PhD., Managing Director, Co-Founder k.m.bode-greuel@bioscience-valuation.com

Date of Incorporation: 2000

Products/Services: BSV provides a broad range of services tailored to the specific needs of each client:

• Pharmaceutical companies
• Biotech/Medtech companies
• Investors
• Strategic alliances

Kontaktdaten
Tel.: +49 8821 966 979-10 /-29
E-Mail: contact@bioscience-valuation.com
Anschrift: Am Zigeunerbergl 3 | 82491 Grainau
Webseite: www.bioscience-valuation.com
Social Media: LinkedIn